Success Metrics

Clinical Success Rate
62.5%

Based on 5 completed trials

Completion Rate
63%(5/8)
Active Trials
1(10%)
Results Posted
40%(2 trials)
Terminated
3(30%)

Phase Distribution

Ph not_applicable
4
40%
Ph phase_1
1
10%
Ph phase_3
1
10%
Ph phase_4
3
30%

Phase Distribution

1

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
3(33.3%)
N/ANon-phased studies
4(44.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

62.5%

5 of 8 finished

Non-Completion Rate

37.5%

3 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(5)
Terminated(3)
Other(1)

Detailed Status

Completed5
Terminated3
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
62.5%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (11.1%)
Phase 31 (11.1%)
Phase 43 (33.3%)
N/A4 (44.4%)

Trials by Status

terminated330%
unknown110%
completed550%
recruiting110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DEVICE
Total Trials
10